the patients were evaluated before treatment , at 15 , 30 , and 90 days during treatment , and then at 90-day intervals during propranolol treatment by clinical examination and measurement of serum free t3 , free t4 , rt3 , tsh , and sex hormone-binding globulin concentrations and serum anti-thyroglobulin , antithyroid microsomal , antithyroid peroxidase , and thyroid-stimulating autoantibodies .
C0220825
evaluated
C0031809
clinical examination